Summary

This bill reauthorizes through FY2029 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve prevention and treatment of sickle cell disease and complications from the disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)

Summary written by the Congressional Research Service, Library of Congress. Heard is not affiliated with it. Written at: Introduced in House, 3/3/2025.

Bill text

Read the full text of the Introduced in House version (3/3/2025), exactly as published — 1,984 characters.

• Introduced in House3/3/2025On HeardOfficial document (HTML)

No roll-call votes recorded for this bill yet.